Your provider evaluates body mass index, weight loss goals, medical conditions, current medications, previous weight loss attempts, and contraindications
For the first time, scientists put both medications head-to-head in a rigorous clinical trial and in May 2025, the results were published in the New England Journal of Medicine , the most respected medical journal in the world.[1] Here in Shreveport and across northwest Louisiana, where nearly 40% of adults are living with obesity, this study matters
Ochiai, T
"The purpose of this study is to learn more about the safety and efficacy of tirzepatide compared to placebo in children or teenagers with Type 2 diabetes taking metformin, or basal insulin, or both," the company wrote
It has caused weeks of nausea that should never have happened